Journal article
Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia
A Barakat, B Dean, E Scarr, G Evin
Schizophrenia Research | ELSEVIER SCIENCE BV | Published : 2010
Abstract
Neuregulin 1 (NRG1) is a susceptibility gene for schizophrenia. A decrease in NRG1-ErbB4 signalling has also been associated with the disease. β-amyloid precursor protein-cleaving enzyme (BACE1) processes type III NRG1 precursor, a major neuregulin variant expressed in the brain, to release NRG1 fragments that trigger signalling events and activation of neurotransmitter receptors. Experimental evidence suggests that muscarinic acetylcholine receptors (CHRM) regulate BACE1 expression. Having recently shown that CHRM1 levels are decreased selectively in frontal cortex regions of a subpopulation of schizophrenic patients (muscarinic receptor deficit schizophrenia, MRDS) we aimed to compare the ..
View full abstractRelated Projects (1)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
We thank Dr Anthony Hannan for critical reading of the manuscript and Dr Cathryn Haigh for help with the statistical analysis This work was supported in part by the NHMRC Project Grants (566520 to G E and 114253 to B D) Melbourne University Department of Pathology Trust Funds and the Rebecca L Cooper Medical Research Foundation E Scarr is supported by a Royce Abbey Postdoctoral Fellowship from the Australian Rotary Health Research Fund Brian Dean is a NHMRC Senior Research Fellow (400016)